References
- Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, Wang WY. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 2003;21:631-7. https://doi.org/10.1200/JCO.2003.06.158
- Kim YJ, Lee SH, Wu HG, Go H, Jeon YK. Immunohistochemical study to evaluate the prognostic significance of four biomolecular markers in radiotherapy of nasopharyngeal carcinoma. J Korean Soc Ther Radiol Oncol 2010;28:57-63. https://doi.org/10.3857/jkstro.2010.28.2.57
- Luan T, Yu Y. Increased hepatocyte growth factor and c-Met receptor expression in nasopharyngeal carcinoma. Int J Clin Exp Med 2014;7:5583-7.
- De Bacco F, Luraghi P, Medico E, et al. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. J Natl Cancer Inst 2011;103:645-61. https://doi.org/10.1093/jnci/djr093
- Liu T, Li Q, Sun Q, et al. MET inhibitor PHA-665752 suppresses the hepatocyte growth factor-induced cell proliferation and radioresistance in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun 2014;449:49-54. https://doi.org/10.1016/j.bbrc.2014.04.147
- Colin-Gonzalez AL, Santana RA, Silva-Islas CA, Chanez-Cardenas ME, Santamaria A, Maldonado PD. The antioxidant mechanisms underlying the aged garlic extract- and S-allylcysteine-induced protection. Oxid Med Cell Longev 2012;2012:907162.
- Chu Q, Lee DT, Tsao SW, Wang X, Wong YC. S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions. BJU Int 2007;99:925-32. https://doi.org/10.1111/j.1464-410X.2006.06639.x
- Gapter LA, Yuin OZ, Ng KY. S-Allylcysteine reduces breast tumor cell adhesion and invasion. Biochem Biophys Res Commun 2008;367:446-51. https://doi.org/10.1016/j.bbrc.2007.12.175
- Tang FY, Chiang EP, Chung JG, Lee HZ, Hsu CY. S-allylcysteine modulates the expression of E-cadherin and inhibits the malignant progression of human oral cancer. J Nutr Biochem 2009;20:1013-20. https://doi.org/10.1016/j.jnutbio.2008.09.007
- Tang FY, Chiang EP, Pai MH. Consumption of S-allylcysteine inhibits the growth of human non-small-cell lung carcinoma in a mouse xenograft model. J Agric Food Chem 2010;58:11156-64. https://doi.org/10.1021/jf102539k
- Welch C, Wuarin L, Sidell N. Antiproliferative effect of the garlic compound S-allyl cysteine on human neuroblastoma cells in vitro. Cancer Lett 1992;63:211-9. https://doi.org/10.1016/0304-3835(92)90263-U
- Ng KT, Guo DY, Cheng Q, et al. A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma. PLoS One 2012;7:e31655. https://doi.org/10.1371/journal.pone.0031655
- Lim YC, Park HY, Hwang HS, et al. (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer Lett 2008;271:140-52. https://doi.org/10.1016/j.canlet.2008.05.048
- Qian CN, Guo X, Cao B, et al. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Res 2002;62:589-96.
- Organ SL, Tsao MS. An overview of the c-MET signaling pathway. Ther Adv Med Oncol 2011;3:S7-S19. https://doi.org/10.1177/1758834011422556
- Eder JP, Vande Woude GF, Boerner SA, LoRusso PM. Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clin Cancer Res 2009;15:2207-14. https://doi.org/10.1158/1078-0432.CCR-08-1306
- Medina-Campos ON, Barrera D, Segoviano-Murillo S, et al. S-allylcysteine scavenges singlet oxygen and hypochlorous acid and protects LLC-PK(1) cells of potassium dichromateinduced toxicity. Food Chem Toxicol 2007;45:2030-9. https://doi.org/10.1016/j.fct.2007.05.002
- Chu Q, Ling MT, Feng H, et al. A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression. Carcinogenesis 2006;27:2180-9. https://doi.org/10.1093/carcin/bgl054
- Chen SY, Chen HC. Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion. Mol Cell Biol 2006;26:5155-67. https://doi.org/10.1128/MCB.02186-05
- Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004;5:816-26. https://doi.org/10.1038/nrm1490
- Zhang K, Chen D, Jiao X, et al. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling. Lab Invest 2011;91:426-38. https://doi.org/10.1038/labinvest.2010.201
- Sivertsen S, Hadar R, Elloul S, et al. Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression. Lung Cancer 2006;54:309-17. https://doi.org/10.1016/j.lungcan.2006.08.010
- Lee BS, Kang S, Kim KA, et al. Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression. Cell Death Dis 2014;5:e1159. https://doi.org/10.1038/cddis.2014.119
- Ferraro D, Corso S, Fasano E, et al. Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS). Oncogene 2006;25:3689-98. https://doi.org/10.1038/sj.onc.1209409
- Jagadeeswaran R, Jagadeeswaran S, Bindokas VP, Salgia R. Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells. Am J Physiol Lung Cell Mol Physiol 2007;292: L1488-94. https://doi.org/10.1152/ajplung.00147.2006
Cited by
- Recent Development of Hydrogen Sulfide Releasing/Stimulating Reagents and Their Potential Applications in Cancer and Glycometabolic Disorders vol.8, pp.None, 2017, https://doi.org/10.3389/fphar.2017.00664
- C1QBP is upregulated in colon cancer and binds to apolipoprotein A-I vol.13, pp.5, 2015, https://doi.org/10.3892/etm.2017.4249
- Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism vol.10, pp.1, 2017, https://doi.org/10.1186/s13045-016-0387-6
- Recent progress in natural dietary non-phenolic bioactives on cancers metastasis vol.26, pp.3, 2015, https://doi.org/10.1016/j.jfda.2018.05.003
- The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular Carcinoma vol.25, pp.10, 2015, https://doi.org/10.3390/molecules25102454